Comet Therapeutics, Inc.
Records under this name other than patents Comet Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Comet Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,624,908 | Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,037,354 | Cyclic Pantetheine Derivatives and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,963,472 | Stable pantetheine derivatives for the treatment of pantothenate kinase associated neurodegeneration (PKAN) and methods for the synthesis of such compounds Formerly held Lapsed on the fee record Ended May 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 8, 2026 | From the USPTO record |